{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T00:45:39Z","timestamp":1794530739305,"version":"4.9.1"},"reference-count":96,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T00:00:00Z","timestamp":1729123200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T00:00:00Z","timestamp":1729123200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100001445","name":"Alex&apos;s Lemonade Stand Foundation for Childhood Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001445","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Alex&apos;s Lemonade Stand Foundation for Childhood Cancer"},{"DOI":"10.13039\/100000065","name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01NS124607"],"award-info":[{"award-number":["R01NS124607"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"},{"id":"https:\/\/ror.org\/01s5ya894","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000065","name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01NS110572"],"award-info":[{"award-number":["R01NS110572"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"},{"id":"https:\/\/ror.org\/01s5ya894","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000065","name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01NS110572"],"award-info":[{"award-number":["R01NS110572"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"},{"id":"https:\/\/ror.org\/01s5ya894","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000065","name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["1R01NS127799"],"award-info":[{"award-number":["1R01NS127799"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"},{"id":"https:\/\/ror.org\/01s5ya894","id-type":"ROR","asserted-by":"crossref"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","id":[{"id":"https:\/\/ror.org\/01s5ya894","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["CA201129P1"],"award-info":[{"award-number":["CA201129P1"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Alex&apos;s Lemonade Stand Foundation for Childhood Cancer"},{"name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","id":[{"id":"https:\/\/ror.org\/01s5ya894","id-type":"ROR","asserted-by":"crossref"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","id":[{"id":"https:\/\/ror.org\/01s5ya894","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA261926"],"award-info":[{"award-number":["R01CA261926"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>H3K27M diffuse midline gliomas (DMG), including diffuse intrinsic pontine gliomas (DIPG), exhibit cellular heterogeneity comprising less-differentiated oligodendrocyte precursors (OPC)-like stem cells and more differentiated astrocyte (AC)-like cells. Here, we establish in vitro models that recapitulate DMG-OPC-like and AC-like phenotypes and perform transcriptomics, metabolomics, and bioenergetic profiling to identify metabolic programs in the different cellular states. We then define strategies to target metabolic vulnerabilities within specific tumor populations. We show that AC-like cells exhibit a mesenchymal phenotype and are sensitized to ferroptotic cell death. In contrast, OPC-like cells upregulate cholesterol biosynthesis, have diminished mitochondrial oxidative phosphorylation (OXPHOS), and are accordingly more sensitive to statins and OXPHOS inhibitors. Additionally, statins and OXPHOS inhibitors show efficacy and extend survival in preclinical orthotopic models established with stem-like H3K27M DMG cells. Together, this study demonstrates that cellular subtypes within DMGs harbor distinct metabolic vulnerabilities that can be uniquely and selectively targeted for therapeutic gain.<\/jats:p>","DOI":"10.1038\/s41467-024-52973-4","type":"journal-article","created":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T18:01:51Z","timestamp":1729188111000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Therapeutic targeting of differentiation-state dependent metabolic vulnerabilities in diffuse midline glioma"],"prefix":"10.1038","volume":"15","author":[{"given":"Nneka E.","family":"Mbah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy L.","family":"Myers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8556-7481","authenticated-orcid":false,"given":"Peter","family":"Sajjakulnukit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0510-8996","authenticated-orcid":false,"given":"Chan","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joyce K.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1202-2808","authenticated-orcid":false,"given":"Hanna S.","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Giza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek","family":"Dang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1641-2045","authenticated-orcid":false,"given":"Zeribe C.","family":"Nwosu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengrou","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan R.","family":"Sweha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniella D.","family":"Maydan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6319-2228","authenticated-orcid":false,"given":"Brandon","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Magnuson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4008-6518","authenticated-orcid":false,"given":"Zirui","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Radyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brooke","family":"Lavoie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viveka Nand","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5816-0627","authenticated-orcid":false,"given":"Imhoi","family":"Koo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2073-0070","authenticated-orcid":false,"given":"Andrew D.","family":"Patterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9894-5085","authenticated-orcid":false,"given":"Daniel R.","family":"Wahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Franchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameer","family":"Agnihotri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl J.","family":"Koschmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sriram","family":"Venneti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9309-6141","authenticated-orcid":false,"given":"Costas A.","family":"Lyssiotis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,17]]},"reference":[{"key":"52973_CR1","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1097\/CCO.0000000000000577","volume":"31","author":"R Aziz-Bose","year":"2019","unstructured":"Aziz-Bose, R. & Monje, M. Diffuse intrinsic pontine glioma: molecular landscape and emerging therapeutic targets. Curr Opin Oncol 31, 522\u2013530 (2019).","journal-title":"Curr Opin Oncol"},{"key":"52973_CR2","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1093\/neuonc\/nox021","volume":"19","author":"KJ Cohen","year":"2017","unstructured":"Cohen, K. J., Jabado, N. & Grill, J. Diffuse intrinsic pontine gliomas-current management and new biologic insights. Is there a glimmer of hope? Neuro Oncol 19, 1025\u20131034 (2017).","journal-title":"Neuro Oncol"},{"key":"52973_CR3","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s11940-019-0577-y","volume":"21","author":"NA Vitanza","year":"2019","unstructured":"Vitanza, N. A. & Monje, M. Diffuse intrinsic pontine glioma: from diagnosis to next-generation clinical trials. Curr Treat Options Neurol 21, 37 (2019).","journal-title":"Curr Treat Options Neurol"},{"key":"52973_CR4","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.adro.2019.03.009","volume":"4","author":"M Gallitto","year":"2019","unstructured":"Gallitto, M. et al. Role of radiation therapy in the management of diffuse intrinsic pontine glioma: a systematic review. Adv Radiat Oncol 4, 520\u2013531 (2019).","journal-title":"Adv Radiat Oncol"},{"key":"52973_CR5","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/ng.1102","volume":"44","author":"G Wu","year":"2012","unstructured":"Wu, G. et al. Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas. Nat Genet 44, 251\u2013253 (2012).","journal-title":"Nat Genet"},{"key":"52973_CR6","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/nature10833","volume":"482","author":"J Schwartzentruber","year":"2012","unstructured":"Schwartzentruber, J. et al. Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma. Nature 482, 226\u2013231 (2012).","journal-title":"Nature"},{"key":"52973_CR7","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s00401-012-0998-0","volume":"124","author":"D-A Khuong-Quang","year":"2012","unstructured":"Khuong-Quang, D.-A. et al. K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas. Acta Neuropathol 124, 439\u2013447 (2012).","journal-title":"Acta Neuropathol"},{"key":"52973_CR8","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s11060-020-03553-1","volume":"150","author":"TM Cooney","year":"2020","unstructured":"Cooney, T. M., Lubanszky, E., Prasad, R., Hawkins, C. & Mueller, S. Diffuse midline glioma: review of epigenetics. J Neurooncol 150, 27\u201334 (2020).","journal-title":"J Neurooncol"},{"key":"52973_CR9","doi-asserted-by":"crossref","unstructured":"Lulla, R. R., Saratsis, A. M. & Hashizume, R. Mutations in chromatin machinery and pediatric high-grade glioma. Science Advances 2, e1501354.","DOI":"10.1126\/sciadv.1501354"},{"key":"52973_CR10","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/ng.2938","volume":"46","author":"G Wu","year":"2014","unstructured":"Wu, G. et al. The genomic landscape of diffuse intrinsic pontine glioma and pediatric non-brainstem high-grade glioma. Nat Genet 46, 444\u2013450 (2014).","journal-title":"Nat Genet"},{"key":"52973_CR11","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1093\/neuonc\/noz218","volume":"22","author":"FM Mendez","year":"2020","unstructured":"Mendez, F. M. et al. Epigenetic reprogramming and chromatin accessibility in pediatric diffuse intrinsic pontine gliomas: a neural developmental disease. Neuro Oncol 22, 195\u2013206 (2020).","journal-title":"Neuro Oncol"},{"key":"52973_CR12","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1126\/science.aao4750","volume":"360","author":"MG Filbin","year":"2018","unstructured":"Filbin, M. G. et al. Developmental and oncogenic programs in H3K27M gliomas dissected by single-cell RNA-seq. Science 360, 331\u2013335 (2018).","journal-title":"Science"},{"key":"52973_CR13","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1038\/s41588-022-01236-3","volume":"54","author":"I Liu","year":"2022","unstructured":"Liu, I. et al. The landscape of tumor cell states and spatial organization in H3-K27M mutant diffuse midline glioma across age and location. Nat Genet 54, 1881\u20131894 (2022).","journal-title":"Nat Genet"},{"key":"52973_CR14","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1038\/s41588-022-01205-w","volume":"54","author":"S Jessa","year":"2022","unstructured":"Jessa, S. et al. K27M in canonical and noncanonical H3 variants occurs in distinct oligodendroglial cell lineages in brain midline gliomas. Nat Genet 54, 1865\u20131880 (2022).","journal-title":"Nat Genet"},{"key":"52973_CR15","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.molcel.2019.05.003","volume":"75","author":"ML Suv\u00e0","year":"2019","unstructured":"Suv\u00e0, M. L. & Tirosh, I. Single-cell RNA sequencing in cancer: lessons learned and emerging challenges. Molecular Cell 75, 7\u201312 (2019).","journal-title":"Molecular Cell"},{"key":"52973_CR16","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.ccell.2018.11.015","volume":"35","author":"JD Larson","year":"2019","unstructured":"Larson, J. D. et al. Histone H3.3 K27M Accelerates spontaneous brainstem glioma and drives restricted changes in bivalent gene expression. Cancer Cell 35, 140\u2013155.e7 (2019).","journal-title":"Cancer Cell"},{"key":"52973_CR17","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/j.molcel.2019.08.030","volume":"76","author":"S Nagaraja","year":"2019","unstructured":"Nagaraja, S. et al. Histone variant and cell context determine H3K27M reprogramming of the enhancer landscape and oncogenic state. Mol Cell 76, 965\u2013980.e12 (2019).","journal-title":"Mol Cell"},{"key":"52973_CR18","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.ccell.2021.01.005","volume":"39","author":"D Haag","year":"2021","unstructured":"Haag, D. et al. H3.3-K27M drives neural stem cell-specific gliomagenesis in a human iPSC-derived model. Cancer Cell 39, 407\u2013422.e13 (2021).","journal-title":"Cancer Cell"},{"key":"52973_CR19","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","volume":"12","author":"D Hanahan","year":"2022","unstructured":"Hanahan, D. Hallmarks of cancer: new dimensions. Cancer Discov 12, 31\u201346 (2022).","journal-title":"Cancer Discov"},{"key":"52973_CR20","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.cell.2016.12.039","volume":"168","author":"MGV Heiden","year":"2017","unstructured":"Heiden, M. G. V. & DeBerardinis, R. J. Understanding the intersections between metabolism and cancer biology. Cell 168, 657\u2013669 (2017).","journal-title":"Cell"},{"key":"52973_CR21","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/j.ccell.2022.07.012","volume":"40","author":"S Pal","year":"2022","unstructured":"Pal, S. et al. A druggable addiction to de novo pyrimidine biosynthesis in diffuse midline glioma. Cancer Cell 40, 957\u2013972.e10 (2022).","journal-title":"Cancer Cell"},{"key":"52973_CR22","doi-asserted-by":"publisher","first-page":"113557","DOI":"10.1016\/j.celrep.2023.113557","volume":"43","author":"SM Casillo","year":"2024","unstructured":"Casillo, S. M. et al. An ERK5-PFKFB3 axis regulates glycolysis and represents a therapeutic vulnerability in pediatric diffuse midline glioma. Cell Rep 43, 113557 (2024).","journal-title":"Cell Rep"},{"key":"52973_CR23","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/s43018-022-00348-3","volume":"3","author":"BJ Golbourn","year":"2022","unstructured":"Golbourn, B. J. et al. Loss of MAT2A compromises methionine metabolism and represents a vulnerability in H3K27M mutant glioma by modulating the epigenome. Nat Cancer 3, 629\u2013648 (2022).","journal-title":"Nat Cancer"},{"key":"52973_CR24","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.ccell.2020.07.008","volume":"38","author":"C Chung","year":"2020","unstructured":"Chung, C. et al. Integrated metabolic and epigenomic reprograming by H3K27M Mutations in Diffuse Intrinsic Pontine Gliomas. Cancer Cell 38, 334\u2013349.e9 (2020).","journal-title":"Cancer Cell"},{"key":"52973_CR25","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1093\/neuonc\/noac041","volume":"24","author":"JM Przystal","year":"2022","unstructured":"Przystal, J. M. et al. Imipridones affect tumor bioenergetics and promote cell lineage differentiation in diffuse midline gliomas. Neuro Oncol 24, 1438\u20131451 (2022).","journal-title":"Neuro Oncol"},{"key":"52973_CR26","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.1158\/2159-8290.CD-23-0131","volume":"13","author":"S Venneti","year":"2023","unstructured":"Venneti, S. et al. Clinical efficacy of ONC201 in H3K27M-mutant diffuse midline gliomas is driven by disruption of integrated metabolic and epigenetic pathways. Cancer Discov 13, 2370\u20132393 (2023).","journal-title":"Cancer Discov"},{"key":"52973_CR27","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1007\/s11060-023-04347-x","volume":"163","author":"B Tanr\u0131kulu","year":"2023","unstructured":"Tanr\u0131kulu, B. et al. Preliminary findings of German-sourced ONC201 treatment in H3K27 altered pediatric pontine diffuse midline gliomas. J Neurooncol 163, 565\u2013575 (2023).","journal-title":"J Neurooncol"},{"key":"52973_CR28","doi-asserted-by":"publisher","unstructured":"Jackson, E. R. et al. ONC201 in Combination with Paxalisib for the Treatment of H3K27-Altered Diffuse Midline Glioma. Cancer Res OF1\u2013OF17 https:\/\/doi.org\/10.1158\/0008-5472.CAN-23-0186 (2023).","DOI":"10.1158\/0008-5472.CAN-23-0186"},{"key":"52973_CR29","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s11060-019-03271-3","volume":"145","author":"AS Chi","year":"2019","unstructured":"Chi, A. S. et al. Pediatric and adult H3 K27M-mutant diffuse midline glioma treated with the selective DRD2 antagonist ONC201. J Neurooncol 145, 97\u2013105 (2019).","journal-title":"J Neurooncol"},{"key":"52973_CR30","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.tcb.2020.09.010","volume":"31","author":"SC Baksh","year":"2021","unstructured":"Baksh, S. C. & Finley, L. W. S. Metabolic coordination of cell fate by \u03b1-Ketoglutarate-dependent dioxygenases. Trends in Cell Biology 31, 24\u201336 (2021).","journal-title":"Trends in Cell Biology"},{"key":"52973_CR31","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s11060-018-03038-2","volume":"141","author":"M Tsoli","year":"2019","unstructured":"Tsoli, M. et al. International experience in the development of patient-derived xenograft models of diffuse intrinsic pontine glioma. J Neurooncol 141, 253\u2013263 (2019).","journal-title":"J Neurooncol"},{"key":"52973_CR32","doi-asserted-by":"publisher","first-page":"76644","DOI":"10.18632\/oncotarget.19656","volume":"8","author":"C Xu","year":"2017","unstructured":"Xu, C. et al. Patient-derived DIPG cells preserve stem-like characteristics and generate orthotopic tumors. Oncotarget 8, 76644\u201376655 (2017).","journal-title":"Oncotarget"},{"key":"52973_CR33","doi-asserted-by":"crossref","unstructured":"Azzarelli, R., Simons, B. D. & Philpott, A. The developmental origin of brain tumours: a cellular and molecular framework. Development 145, dev162693 (2018).","DOI":"10.1242\/dev.162693"},{"key":"52973_CR34","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1038\/s41591-018-0086-7","volume":"24","author":"M Vinci","year":"2018","unstructured":"Vinci, M. et al. Functional diversity and cooperativity between subclonal populations of pediatric glioblastoma and diffuse intrinsic pontine glioma cells. Nat Med 24, 1204\u20131215 (2018).","journal-title":"Nat Med"},{"key":"52973_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40478-015-0269-0","volume":"4","author":"LM Hoffman","year":"2016","unstructured":"Hoffman, L. M. et al. Spatial genomic heterogeneity in diffuse intrinsic pontine and midline high-grade glioma: implications for diagnostic biopsy and targeted therapeutics. Acta Neuropathol Commun 4, 1 (2016).","journal-title":"Acta Neuropathol Commun"},{"key":"52973_CR36","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1093\/neuonc\/now299","volume":"19","author":"JL Anderson","year":"2017","unstructured":"Anderson, J. L. et al. The transcription factor Olig2 is important for the biology of diffuse intrinsic pontine gliomas. Neuro Oncol 19, 1068\u20131078 (2017).","journal-title":"Neuro Oncol"},{"key":"52973_CR37","doi-asserted-by":"publisher","first-page":"2683","DOI":"10.1101\/gad.1596707","volume":"21","author":"FB Furnari","year":"2007","unstructured":"Furnari, F. B. et al. Malignant astrocytic glioma: genetics, biology, and paths to treatment. Genes Dev 21, 2683\u20132710 (2007).","journal-title":"Genes Dev"},{"key":"52973_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-017-0425-9","volume":"5","author":"AA Sosunov","year":"2017","unstructured":"Sosunov, A. A., McKhann, G. M. & Goldman, J. E. The origin of Rosenthal fibers and their contributions to astrocyte pathology in Alexander disease. Acta Neuropathologica Communications 5, 27 (2017).","journal-title":"Acta Neuropathologica Communications"},{"key":"52973_CR39","doi-asserted-by":"publisher","unstructured":"Yadav, V. N. et al. Therapeutic reversal of prenatal pontine ID1 signaling in DIPG. 2021.05.10.443452 at https:\/\/doi.org\/10.1101\/2021.05.10.443452 (2021).","DOI":"10.1101\/2021.05.10.443452"},{"key":"52973_CR40","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.ccell.2017.08.017","volume":"32","author":"A Mackay","year":"2017","unstructured":"Mackay, A. et al. Integrated molecular meta-analysis of 1000 pediatric high-grade and diffuse intrinsic pontine glioma. Cancer Cell 32, 520\u2013537.e5 (2017).","journal-title":"Cancer Cell"},{"key":"52973_CR41","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3389\/fonc.2017.00057","volume":"7","author":"DH Lapin","year":"2017","unstructured":"Lapin, D. H., Tsoli, M. & Ziegler, D. S. Genomic insights into diffuse intrinsic pontine glioma. Front Oncol 7, 57 (2017).","journal-title":"Front Oncol"},{"key":"52973_CR42","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1007\/s00401-013-1218-2","volume":"127","author":"AM Saratsis","year":"2014","unstructured":"Saratsis, A. M. et al. Comparative multidimensional molecular analyses of pediatric diffuse intrinsic pontine glioma reveals distinct molecular subtypes. Acta Neuropathol 127, 881\u2013895 (2014).","journal-title":"Acta Neuropathol"},{"key":"52973_CR43","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/nature19084","volume":"536","author":"CM Sousa","year":"2016","unstructured":"Sousa, C. M. et al. Pancreatic stellate cells support tumour metabolism through autophagic alanine secretion. Nature 536, 479\u2013483 (2016).","journal-title":"Nature"},{"key":"52973_CR44","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/nn.4537","volume":"20","author":"X Wang","year":"2017","unstructured":"Wang, X. et al. Purine synthesis promotes maintenance of brain tumor initiating cells in glioma. Nat Neurosci 20, 661\u2013673 (2017).","journal-title":"Nat Neurosci"},{"key":"52973_CR45","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/nchembio.2517","volume":"14","author":"BA Beyer","year":"2018","unstructured":"Beyer, B. A. et al. Metabolomics-based discovery of a metabolite that enhances oligodendrocyte maturation. Nat Chem Biol 14, 22\u201328 (2018).","journal-title":"Nat Chem Biol"},{"key":"52973_CR46","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nature23007","volume":"547","author":"VS Viswanathan","year":"2017","unstructured":"Viswanathan, V. S. et al. Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway. Nature 547, 453\u2013457 (2017).","journal-title":"Nature"},{"key":"52973_CR47","doi-asserted-by":"publisher","first-page":"101697","DOI":"10.1016\/j.redox.2020.101697","volume":"37","author":"J Lee","year":"2020","unstructured":"Lee, J., You, J. H., Kim, M.-S. & Roh, J.-L. Epigenetic reprogramming of epithelial-mesenchymal transition promotes ferroptosis of head and neck cancer. Redox Biol 37, 101697 (2020).","journal-title":"Redox Biol"},{"key":"52973_CR48","doi-asserted-by":"publisher","unstructured":"Mbah, N. E. & Lyssiotis, C. A. Metabolic regulation of ferroptosis in the tumor microenvironment. J Biol Chem 101617 (2022) https:\/\/doi.org\/10.1016\/j.jbc.2022.101617.","DOI":"10.1016\/j.jbc.2022.101617"},{"key":"52973_CR49","doi-asserted-by":"publisher","first-page":"4551","DOI":"10.1021\/ja411006a","volume":"136","author":"R Skouta","year":"2014","unstructured":"Skouta, R. et al. Ferrostatins inhibit oxidative lipid damage and cell death in diverse disease models. J Am Chem Soc 136, 4551\u20134556 (2014).","journal-title":"J Am Chem Soc"},{"key":"52973_CR50","doi-asserted-by":"publisher","first-page":"5313","DOI":"10.1172\/JCI133310","volume":"130","author":"Z Miklja","year":"2020","unstructured":"Miklja, Z. et al. Everolimus improves the efficacy of dasatinib in PDGFR\u03b1-driven glioma. J Clin Invest 130, 5313\u20135325 (2020).","journal-title":"J Clin Invest"},{"key":"52973_CR51","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1146\/annurev.biochem.68.1.157","volume":"68","author":"PA Edwards","year":"1999","unstructured":"Edwards, P. A. & Ericsson, J. Sterols and isoprenoids: signaling molecules derived from the cholesterol biosynthetic pathway. Annual Review of Biochemistry 68, 157\u2013185 (1999).","journal-title":"Annual Review of Biochemistry"},{"key":"52973_CR52","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1111\/j.1440-1681.2007.04565.x","volume":"34","author":"AJ Brown","year":"2007","unstructured":"Brown, A. J. Cholesterol, statins and cancer. Clinical and Experimental Pharmacology and Physiology 34, 135\u2013141 (2007).","journal-title":"Clinical and Experimental Pharmacology and Physiology"},{"key":"52973_CR53","doi-asserted-by":"publisher","first-page":"13106","DOI":"10.1096\/fj.202000767R","volume":"34","author":"P Marchetti","year":"2020","unstructured":"Marchetti, P., Fovez, Q., Germain, N., Khamari, R. & Kluza, J. Mitochondrial spare respiratory capacity: mechanisms, regulation, and significance in non-transformed and cancer cells. The FASEB Journal 34, 13106\u201313124 (2020).","journal-title":"The FASEB Journal"},{"key":"52973_CR54","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/B978-0-12-801415-8.00016-3","volume":"547","author":"AS Divakaruni","year":"2014","unstructured":"Divakaruni, A. S., Paradyse, A., Ferrick, D. A., Murphy, A. N. & Jastroch, M. Analysis and interpretation of microplate-based oxygen consumption and pH data. Methods Enzymol 547, 309\u2013354 (2014).","journal-title":"Methods Enzymol"},{"key":"52973_CR55","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1128\/jb.108.3.1072-1086.1971","volume":"108","author":"AG Chapman","year":"1971","unstructured":"Chapman, A. G., Fall, L. & Atkinson, D. E. Adenylate energy charge in Escherichia coli during growth and starvation. J Bacteriol 108, 1072\u20131086 (1971).","journal-title":"J Bacteriol"},{"key":"52973_CR56","doi-asserted-by":"publisher","first-page":"e108676","DOI":"10.1371\/journal.pone.0108676","volume":"9","author":"IM De la Fuente","year":"2014","unstructured":"De la Fuente, I. M. et al. On the dynamics of the adenylate energy system: homeorhesis vs homeostasis. PLoS One 9, e108676 (2014).","journal-title":"PLoS One"},{"key":"52973_CR57","doi-asserted-by":"publisher","first-page":"13","DOI":"10.4137\/LPI.S37450","volume":"9","author":"JT Davies","year":"2016","unstructured":"Davies, J. T. et al. Current and emerging uses of statins in clinical therapeutics: a review. Lipid Insights 9, 13\u201329 (2016).","journal-title":"Lipid Insights"},{"key":"52973_CR58","first-page":"413","volume":"20","author":"YK Chae","year":"2015","unstructured":"Chae, Y. K. et al. Statins as anti-cancer therapy; Can we translate preclinical and epidemiologic data into clinical benefit? Discov Med 20, 413\u2013427 (2015).","journal-title":"Discov Med"},{"key":"52973_CR59","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1007\/s12032-011-9846-7","volume":"29","author":"TV Kourelis","year":"2012","unstructured":"Kourelis, T. V. & Siegel, R. D. Metformin and cancer: new applications for an old drug. Med Oncol 29, 1314\u20131327 (2012).","journal-title":"Med Oncol"},{"key":"52973_CR60","first-page":"683","volume":"15","author":"F Zi","year":"2018","unstructured":"Zi, F. et al. Metformin and cancer: an existing drug for cancer prevention and therapy. Oncol Lett 15, 683\u2013690 (2018).","journal-title":"Oncol Lett"},{"key":"52973_CR61","doi-asserted-by":"publisher","first-page":"56456","DOI":"10.18632\/oncotarget.10919","volume":"7","author":"W Jiang","year":"2016","unstructured":"Jiang, W. et al. Repurposing phenformin for the targeting of glioma stem cells and the treatment of glioblastoma. Oncotarget 7, 56456\u201356470 (2016).","journal-title":"Oncotarget"},{"key":"52973_CR62","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.2337\/db14-0287","volume":"63","author":"M Yarchoan","year":"2014","unstructured":"Yarchoan, M. & Arnold, S. E. Repurposing diabetes drugs for brain insulin resistance in Alzheimer disease. Diabetes 63, 2253\u20132261 (2014).","journal-title":"Diabetes"},{"key":"52973_CR63","doi-asserted-by":"publisher","first-page":"307","DOI":"10.3233\/JAD-2010-101179","volume":"23","author":"S Sierra","year":"2011","unstructured":"Sierra, S. et al. Statins as neuroprotectants: a comparative in vitro study of lipophilicity, blood-brain-barrier penetration, lowering of brain cholesterol, and decrease of neuron cell death. J Alzheimers Dis 23, 307\u2013318 (2011).","journal-title":"J Alzheimers Dis"},{"key":"52973_CR64","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1001\/archneurol.2011.242","volume":"68","author":"NE Shepardson","year":"2011","unstructured":"Shepardson, N. E., Shankar, G. M. & Selkoe, D. J. Cholesterol level and statin use in Alzheimer disease: II. review of human trials and recommendations. Arch Neurol 68, 1385\u20131392 (2011).","journal-title":"Arch Neurol"},{"key":"52973_CR65","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1177\/1073858418793077","volume":"25","author":"L Rosko","year":"2019","unstructured":"Rosko, L., Smith, V. N., Yamazaki, R. & Huang, J. K. Oligodendrocyte bioenergetics in health and disease. Neuroscientist 25, 334\u2013343 (2019).","journal-title":"Neuroscientist"},{"key":"52973_CR66","first-page":"756","volume":"7","author":"N Yang","year":"2012","unstructured":"Yang, N., Xu, L., Lin, P. & Cui, J. Uric acid promotes neuronal differentiation of human placenta-derived mesenchymal stem cells in a time- and concentration-dependent manner. Neural Regen Res 7, 756\u2013760 (2012).","journal-title":"Neural Regen Res"},{"key":"52973_CR67","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.exer.2018.05.004","volume":"173","author":"S Vidhya","year":"2018","unstructured":"Vidhya, S., Ramya, R., Coral, K., Sulochana, K. N. & Bharathidevi, S. R. Free amino acids hydroxyproline, lysine, and glycine promote differentiation of retinal pericytes to adipocytes: A protective role against proliferative diabetic retinopathy. Experimental Eye Research 173, 179\u2013187 (2018).","journal-title":"Experimental Eye Research"},{"key":"52973_CR68","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/s41586-023-06878-9","volume":"626","author":"FP Freitas","year":"2024","unstructured":"Freitas, F. P. et al. 7-Dehydrocholesterol is an endogenous suppressor of ferroptosis. Nature 626, 401\u2013410 (2024).","journal-title":"Nature"},{"key":"52973_CR69","doi-asserted-by":"publisher","first-page":"e3769","DOI":"10.1371\/journal.pone.0003769","volume":"3","author":"J Wang","year":"2008","unstructured":"Wang, J. et al. c-Myc Is required for maintenance of glioma cancer stem cells. PLoS One 3, e3769 (2008).","journal-title":"PLoS One"},{"key":"52973_CR70","doi-asserted-by":"publisher","first-page":"7500","DOI":"10.1158\/0008-5472.CAN-10-2353","volume":"70","author":"S Mazzoleni","year":"2010","unstructured":"Mazzoleni, S. et al. Epidermal growth factor receptor expression identifies functionally and molecularly distinct tumor-initiating cells in human glioblastoma multiforme and is required for gliomagenesis. Cancer Res 70, 7500\u20137513 (2010).","journal-title":"Cancer Res"},{"key":"52973_CR71","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1515\/BC.2009.035","volume":"390","author":"JM Dietschy","year":"2009","unstructured":"Dietschy, J. M. Central nervous system: cholesterol turnover, brain development and neurodegeneration. Biol Chem 390, 287\u2013293 (2009).","journal-title":"Biol Chem"},{"key":"52973_CR72","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1161\/01.ATV.0000120374.59826.1b","volume":"24","author":"I Bj\u00f6rkhem","year":"2004","unstructured":"Bj\u00f6rkhem, I. & Meaney, S. Brain cholesterol: long secret life behind a barrier. Arterioscler Thromb Vasc Biol 24, 806\u2013815 (2004).","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"52973_CR73","doi-asserted-by":"publisher","first-page":"4049","DOI":"10.1074\/jbc.M508915200","volume":"281","author":"B Karten","year":"2006","unstructured":"Karten, B., Campenot, R. B., Vance, D. E. & Vance, J. E. Expression of ABCG1, but not ABCA1, correlates with cholesterol release by cerebellar astroglia. J Biol Chem 281, 4049\u20134057 (2006).","journal-title":"J Biol Chem"},{"key":"52973_CR74","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.ccell.2016.09.008","volume":"30","author":"GR Villa","year":"2016","unstructured":"Villa, G. R. et al. An LXR-cholesterol axis creates a metabolic Co-dependency for brain cancers. Cancer Cell 30, 683\u2013693 (2016).","journal-title":"Cancer Cell"},{"key":"52973_CR75","doi-asserted-by":"publisher","first-page":"7957","DOI":"10.1073\/pnas.1820989116","volume":"116","author":"RE Phillips","year":"2019","unstructured":"Phillips, R. E. et al. Target identification reveals lanosterol synthase as a vulnerability in glioma. Proc Natl Acad Sci USA 116, 7957\u20137962 (2019).","journal-title":"Proc Natl Acad Sci USA"},{"key":"52973_CR76","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/j.cmet.2014.09.018","volume":"20","author":"M Foretz","year":"2014","unstructured":"Foretz, M., Guigas, B., Bertrand, L., Pollak, M. & Viollet, B. Metformin: from mechanisms of action to therapies. Cell Metab 20, 953\u2013966 (2014).","journal-title":"Cell Metab"},{"key":"52973_CR77","doi-asserted-by":"publisher","first-page":"3693","DOI":"10.1172\/JCI67232","volume":"123","author":"M Pollak","year":"2013","unstructured":"Pollak, M. Potential applications for biguanides in oncology. J Clin Invest 123, 3693\u20133700 (2013).","journal-title":"J Clin Invest"},{"key":"52973_CR78","doi-asserted-by":"publisher","first-page":"5085","DOI":"10.1158\/1078-0432.CCR-14-1038","volume":"20","author":"D Karnak","year":"2014","unstructured":"Karnak, D. et al. Combined inhibition of Wee1 and PARP1\/2 for radiosensitization in pancreatic cancer. Clin Cancer Res 20, 5085\u20135096 (2014).","journal-title":"Clin Cancer Res"},{"key":"52973_CR79","doi-asserted-by":"publisher","DOI":"10.1007\/s11306-019-1564-8","volume":"15","author":"H-J Lee","year":"2019","unstructured":"Lee, H.-J., Kremer, D. M., Sajjakulnukit, P., Zhang, L. & Lyssiotis, C. A. A large-scale analysis of targeted metabolomics data from heterogeneous biological samples provides insights into metabolite dynamics. Metabolomics 15, 103 (2019).","journal-title":"Metabolomics"},{"key":"52973_CR80","doi-asserted-by":"publisher","first-page":"e73245","DOI":"10.7554\/eLife.73245","volume":"11","author":"SA Kerk","year":"2022","unstructured":"Kerk, S. A. et al. Metabolic requirement for GOT2 in pancreatic cancer depends on environmental context. Elife 11, e73245 (2022).","journal-title":"Elife"},{"key":"52973_CR81","doi-asserted-by":"publisher","unstructured":"Bielawski, J. et al. Comprehensive Quantitative Analysis of Bioactive Sphingolipids by High-Performance Liquid Chromatography\u2013Tandem Mass Spectrometry. in Lipidomics: Volume 1: Methods and Protocols (ed. Armstrong, D.) 443\u2013467 (Humana Press, Totowa, NJ, 2009). https:\/\/doi.org\/10.1007\/978-1-60761-322-0_22.","DOI":"10.1007\/978-1-60761-322-0_22"},{"key":"52973_CR82","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1038\/nbt.2377","volume":"30","author":"MC Chambers","year":"2012","unstructured":"Chambers, M. C. et al. A cross-platform toolkit for mass spectrometry and proteomics. Nat Biotechnol 30, 918\u2013920 (2012).","journal-title":"Nat Biotechnol"},{"key":"52973_CR83","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/nmeth.3393","volume":"12","author":"H Tsugawa","year":"2015","unstructured":"Tsugawa, H. et al. MS-DIAL: data-independent MS\/MS deconvolution for comprehensive metabolome analysis. Nat Methods 12, 523\u2013526 (2015).","journal-title":"Nat Methods"},{"key":"52973_CR84","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","volume":"30","author":"AM Bolger","year":"2014","unstructured":"Bolger, A. M., Lohse, M. & Usadel, B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics 30, 2114\u20132120 (2014).","journal-title":"Bioinformatics"},{"key":"52973_CR85","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-12-323","volume":"12","author":"B Li","year":"2011","unstructured":"Li, B. & Dewey, C. N. RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinformatics 12, 323 (2011).","journal-title":"BMC Bioinformatics"},{"key":"52973_CR86","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15\u201321 (2013).","journal-title":"Bioinformatics"},{"key":"52973_CR87","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1093\/bioinformatics\/bty895","volume":"35","author":"A Zhu","year":"2019","unstructured":"Zhu, A., Ibrahim, J. G. & Love, M. I. Heavy-tailed prior distributions for sequence count data: removing the noise and preserving large differences. Bioinformatics 35, 2084\u20132092 (2019).","journal-title":"Bioinformatics"},{"key":"52973_CR88","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2012-13-12-r113","volume":"13","author":"M Parker","year":"2012","unstructured":"Parker, M. et al. Assessing telomeric DNA content in pediatric cancers using whole-genome sequencing data. Genome Biol 13, R113 (2012).","journal-title":"Genome Biol"},{"key":"52973_CR89","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/ng.2936","volume":"46","author":"P Buczkowicz","year":"2014","unstructured":"Buczkowicz, P. et al. Genomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutations. Nat Genet 46, 451\u2013456 (2014).","journal-title":"Nat Genet"},{"key":"52973_CR90","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1038\/ng.2950","volume":"46","author":"AM Fontebasso","year":"2014","unstructured":"Fontebasso, A. M. et al. Recurrent somatic mutations in ACVR1 in pediatric midline high-grade astrocytoma. Nat Genet 46, 462\u2013466 (2014).","journal-title":"Nat Genet"},{"key":"52973_CR91","doi-asserted-by":"publisher","first-page":"3061","DOI":"10.1200\/JCO.2009.26.7252","volume":"28","author":"BS Paugh","year":"2010","unstructured":"Paugh, B. S. et al. Integrated molecular genetic profiling of pediatric high-grade gliomas reveals key differences with the adult disease. J Clin Oncol 28, 3061\u20133068 (2010).","journal-title":"J Clin Oncol"},{"key":"52973_CR92","doi-asserted-by":"publisher","first-page":"3999","DOI":"10.1200\/JCO.2011.35.5677","volume":"29","author":"BS Paugh","year":"2011","unstructured":"Paugh, B. S. et al. Genome-wide analyses identify recurrent amplifications of receptor tyrosine kinases and cell-cycle regulatory genes in diffuse intrinsic pontine glioma. J Clin Oncol 29, 3999\u20134006 (2011).","journal-title":"J Clin Oncol"},{"key":"52973_CR93","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1093\/neuonc\/noq158","volume":"2","author":"J Barrow","year":"2011","unstructured":"Barrow, J. et al. Homozygous loss of ADAM3A revealed by genome-wide analysis of pediatric high-grade glioma and diffuse intrinsic pontine gliomas. Neuro Oncol 2, 212\u2013222 (2011).","journal-title":"Neuro Oncol"},{"key":"52973_CR94","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.ccr.2012.08.024","volume":"22","author":"D Sturm","year":"2012","unstructured":"Sturm, D. et al. Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma. Cancer Cell 22, 425\u2013437 (2012).","journal-title":"Cancer Cell"},{"key":"52973_CR95","doi-asserted-by":"publisher","first-page":"3420","DOI":"10.1158\/1535-7163.MCT-08-0629","volume":"7","author":"CA Payne","year":"2008","unstructured":"Payne, C. A. et al. Loss of prostaglandin D2 synthase: a key molecular event in the transition of a low-grade astrocytoma to an anaplastic astrocytoma. Mol Cancer Ther 7, 3420\u20133428 (2008).","journal-title":"Mol Cancer Ther"},{"key":"52973_CR96","doi-asserted-by":"publisher","first-page":"e30313","DOI":"10.1371\/journal.pone.0030313","volume":"7","author":"S Puget","year":"2012","unstructured":"Puget, S. et al. Mesenchymal transition and PDGFRA amplification\/mutation are key distinct oncogenic events in pediatric diffuse intrinsic pontine gliomas. PLoS One 7, e30313 (2012).","journal-title":"PLoS One"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-52973-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-52973-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-52973-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,20]],"date-time":"2024-10-20T22:02:29Z","timestamp":1729461749000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-52973-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,17]]},"references-count":96,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["52973"],"URL":"https:\/\/doi.org\/10.1038\/s41467-024-52973-4","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,17]]},"assertion":[{"value":"1 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"In the past three years, C.A.L. has consulted for Astellas Pharmaceuticals, Odyssey Therapeutics, Third Rock Ventures, and T-Knife Therapeutics, and is an inventor on patents pertaining to K-Ras regulated metabolic pathways, redox control pathways in pancreatic cancer, and targeting the GOT1-ME1 pathway as a therapeutic approach (US Patent No: 2015126580-A1, 05\/07\/2015; US Patent No: 20190136238, 05\/09\/2019; International Patent No: WO2013177426-A2, 04\/23\/2015). All other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8983"}}